期刊文献+

树突状细胞对APL凋亡细胞溶解抗原交叉提呈诱导产生的抗白血病效应

Antileukemic activity induced by DCs cross presenting apoptotic APL cells lysate antigen
在线阅读 下载PDF
导出
摘要 目的:研究树突状细胞(DC)在体外对恶性肿瘤凋亡细胞溶解抗原交叉提呈的可能性及由此诱导产生的抗瘤效应.方法:用As2O3体外诱导急性早幼粒白血病(APL)细胞凋亡.取患者完全缓解期(CR)外周血单个核细胞(PBMNC)体外诱导DC,体外进行APL凋亡细胞溶解抗原(ALA)负载,并设APL细胞溶解抗原(CLA)负载对照,ALADC激自体T细胞,流式细胞术分析DC,T细胞免疫表型.51Cr释放法测定T细胞对APL细胞杀伤活性.结果:APL细胞经2μmol/LAs2O3体外诱导5d,凋亡率为(86±4)%;自体T细胞被DC激化前,CD2+,CD3+,CD8+T细胞百分率为(27±5)%;被ALADC激活后,CD2+,CD3+,CD8+T细胞百分率上升至(50±12)%,对照组下降至(22±4)%.细胞毒性实验示ALADC激活的自体T细胞对APL细胞的杀伤活性明显强于对照组(P<0.01).结论:APL凋亡细胞溶解抗原能被DC交叉提呈,激活CD8+CTL细胞,其诱导的抗白血病效应强于非凋亡细胞溶解抗原致敏的DC. AIM: To investigate the possibility of dendritic cells (DCs) cross presenting apoptotic leukemic cells lysate antigen and inducing anti-leukemic immune activity. METHODS: The apoptosis of acute promyelocytic leukemia (APL) cells was induced by arsenic trioxied. DCs derived from peripheral blood mononuclear cells (PBMNC) of patients in complete remission (CR) were pulsed with apoptotic APL cells lysate antigen (ALA) and compared with those pulsed with APL cells lysate antigen (CLA). The phonetypes of T cells and DCs were tested by flow cytometry and the cytotoxicity was tested by 51Cr release assay. RESULTS: The flow cytometry analysis showed that the apoptotic indexes were respectively (86±4)% for the APL cells induced by 2 μmol/L arsenic trioxied for five days in vitro, (27±5)% for the auto-T cells expressing CD2, CD3 and CD8 before cocultured with DCs, (50±12)% after cocultivated with ALA-DCs and (22±4)% after cocultivated with CLA-DCs. T cells activated by ALA-DCs had greater cytotoxicity against APL cells than those activated by CLA-DCs. CONCLUSION: DCs can effectively cross present apoptotic APL cells lysate antigen in vitro and activate specific CD8+CTL. These cells have greater anti-leukemic effects than those activated by CLA-DCs.
出处 《第四军医大学学报》 北大核心 2005年第14期1282-1284,共3页 Journal of the Fourth Military Medical University
关键词 树突细胞 抗原呈递 细胞凋亡 白血病 早幼粒细胞 急性 dendritic cells antigen presentation apoptosis leukemia, promyelocytic, acute
  • 相关文献

参考文献10

  • 1Takahashi T. Dendritic cell therapy Nippon Rinsho [J]. Rev Japn,2001 ;59:2421 - 2426.
  • 2Scott ES, Stephen V, Ryan W, et al. Strategies for antigen loading of dendritic cells to enhance the antitumor immune response [ J ].Cancer Res, 2002 ;62 ( 6 ): 1884 - 1889.
  • 3朱学军,曹雪涛,于益芝,陈国友,万涛,马施华,唐华,章卫平.人外周血树突状细胞的体外扩增及鉴定[J].中国肿瘤生物治疗杂志,1997,4(4):302-306. 被引量:91
  • 4Reid DC. Dendritic cells and immunotherapy for malignant disease[J]. BJ Haematol, 2001 ;112:874 - 887.
  • 5曹雪涛.树突状细胞与肿瘤的免疫治疗和基因治疗——树突状细胞的细胞与分子生物学Keystone会议(美国)简介[J].中国肿瘤生物治疗杂志,1998,5(2):82-84. 被引量:20
  • 6Orsini E, Foa R. Dendritic cell generation for leukemia immunotherapy [J]. Leuks Res, 2002; 26:409 -410.
  • 7Akiyama K, Ebihara S, Yada A, et al. Targeting apoptotic tumor cells to Fc gamma R provides efficient and versatile vaccination against tumors by dendritic cells [ J]. Immunology, 2003;170 (4):1641 - 1648.
  • 8Labarriere N, Bretaudeau L, Gervois N, et al. Apoptopic body-loaded dendritic cells efficiently cross-prime cytotoxic T lymphocytes specific for NA17-A antigen but not for Melan-A/MART-1 antigen [ J].Cancer, 2002; 101 (3) :280 - 286.
  • 9Albert ML, Stanter B, Bhardwaj N. Dendritic cells acquire antigen from apoptotic cells and induce class-I restricted [ J ]. Nature,1998 ;392:86 - 89.
  • 10Guido F, Claudia S, Grazia M , et al. Dendritic cells efficiently cross-prime HLA class I-restricted cytolytic T lymphocytes when pulsed with both apoptotic and necrotic cells but not with soluble cell-derived lysates [ J ]. Japn Soc lmmunol, 2001; 12 ( 12 ):1741 - 1749.

共引文献108

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部